Figure 42.
CTA multiphasic study of rectal bleeding during treatment with VEGF inhibitors. The pre-contrast (a) and arterial (b) phases show the presence of bleeding in the rectal wall (b, arrow) of a patient treated with Bevacizumab.
Official websites use .gov
A
.gov website belongs to an official
government organization in the United States.
Secure .gov websites use HTTPS
A lock (
) or https:// means you've safely
connected to the .gov website. Share sensitive
information only on official, secure websites.